The U.S. Supreme Court ruled Thursday that pro-life doctors do not have standing to challenge the Food and Drug Administration’s removal of safety restrictions on abortion drugs.
The court issued a unanimous ruling in two combined cases that deal with the FDA’s regulation of abortion drugs, FDA v. Alliance for Hippocratic Medicine and Danco Laboratories LLC v. Alliance for Hippocratic Medicine.
Justice Brett Kavanaugh delivered the opinion of the Court, in which he wrote that even though the plaintiffs have “sincere legal, moral, ideological, and policy objections to elective abortion and to the FDA’s relaxed regulation of mifepristone,” because they do not prescribe or use the abortion drug mifepristone, and the FDA is not requiring them to “do or refrain from doing anything,” “the plaintiffs lack standing to challenge FDA’s actions.”
“In…
